BLOG

Fierce-Biotech

After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B

It’s been a nice month for Pyxis Oncology: After penning a major licensing deal with Pfizer, the startup now has $152 million extra in the bank to help it push on with its expanded pipeline.